BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Warnecke T, Schäfer KH, Claus I, Del Tredici K, Jost WH. Gastrointestinal involvement in Parkinson's disease: pathophysiology, diagnosis, and management. NPJ Parkinsons Dis 2022;8:31. [PMID: 35332158 DOI: 10.1038/s41531-022-00295-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Lima IS, Pêgo AC, Martins AC, Prada AR, Barros T, Martins G, Gozzelino R. Gut Dysbiosis: A Target for Protective Interventions against Parkinson’s Disease. Microorganisms 2023;11:880. [DOI: 10.3390/microorganisms11040880] [Reference Citation Analysis]
2 Wellach I. Management nicht-motorischer Störungen bei Morbus Parkinson – Schritt für Schritt. Neurologie up2date 2023;06:14-24. [DOI: 10.1055/a-1725-1327] [Reference Citation Analysis]
3 Grund KE, Zipfel A, Duckworth-Mothes B, Jost WH. Optimised endoscopic access for intrajejunal levodopa application in idiopathic Parkinson's syndrome. J Neural Transm (Vienna) 2023. [PMID: 36809488 DOI: 10.1007/s00702-023-02601-0] [Reference Citation Analysis]
4 Sheikhpour E, Mard SA, Farbood Y, Bavarsad K, Sarkaki A. The effects of gallic acid and vagotomy on motor function, intestinal transit, brain electrophysiology and oxidative stress alterations in a rat model of Parkinson's disease induced by rotenone. Life Sci 2023;315:121356. [PMID: 36621537 DOI: 10.1016/j.lfs.2022.121356] [Reference Citation Analysis]
5 Leta V, Klingelhoefer L, Longardner K, Campagnolo M, Levent HÇ, Aureli F, Metta V, Bhidayasiri R, Chung-Faye G, Falup-Pecurariu C, Stocchi F, Jenner P, Warnecke T, Ray Chaudhuri K; International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group. Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease. Eur J Neurol 2023. [PMID: 36757008 DOI: 10.1111/ene.15734] [Reference Citation Analysis]
6 Warnecke T, Lummer C, Rey JW, Claus I, Lüttje D. [Parkinson's disease]. Inn Med (Heidelb) 2023;64:131-8. [PMID: 36480073 DOI: 10.1007/s00108-022-01444-3] [Reference Citation Analysis]
7 Song LZ, Li Y, Qian X, Xu N, Yu Z, Dai JW, Xu B, Hu XM. Parkinson's disease constipation effect of electroacupuncture at ST25 through colonic motility and enteric neuropathology. Front Neurol 2022;13:1092127. [PMID: 36733445 DOI: 10.3389/fneur.2022.1092127] [Reference Citation Analysis]
8 Pellegrini C, Fornai M, D'Antongiovanni V, Antonioli L, Bernardini N, Derkinderen P. The intestinal barrier in disorders of the central nervous system. Lancet Gastroenterol Hepatol 2023;8:66-80. [PMID: 36334596 DOI: 10.1016/S2468-1253(22)00241-2] [Reference Citation Analysis]
9 Moin K, Funk C, Josephs M, Coombes K, Yeakle M, Gala D, Ahmed-Khan M. Gut-brain axis: Review on the association between Parkinson's disease and plant lectins. Arch Clin Cases 2022;9:177-83. [PMID: 36628158 DOI: 10.22551/2022.37.0904.10228] [Reference Citation Analysis]
10 Bianco F, Lattanzio G, Lorenzini L, Mazzoni M, Clavenzani P, Calzà L, Giardino L, Sternini C, Costanzini A, Bonora E, De Giorgio R. Enteric Neuromyopathies: Highlights on Genetic Mechanisms Underlying Chronic Intestinal Pseudo-Obstruction. Biomolecules 2022;12. [PMID: 36551277 DOI: 10.3390/biom12121849] [Reference Citation Analysis]
11 Chen SJ, Lin CH. Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis. J Biomed Sci 2022;29:54. [PMID: 35897024 DOI: 10.1186/s12929-022-00839-6] [Reference Citation Analysis]
12 Minakawa EN. Bidirectional Relationship Between Sleep Disturbances and Parkinson's Disease. Front Neurol 2022;13:927994. [DOI: 10.3389/fneur.2022.927994] [Reference Citation Analysis]
13 Zhu M, Liu X, Ye Y, Yan X, Cheng Y, Zhao L, Chen F, Ling Z. Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease. Front Immunol 2022;13:937555. [DOI: 10.3389/fimmu.2022.937555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Xu J, Wang L, Chen X, Le W. New Understanding on the Pathophysiology and Treatment of Constipation in Parkinson’s Disease. Front Aging Neurosci 2022;14:917499. [DOI: 10.3389/fnagi.2022.917499] [Reference Citation Analysis]
15 Pilipovich A, Vorob’eva O. Upper gastrointestinal tract dysfunction and its correction by dopamine agonists for patients with Parkinson’s disease of I—III stage. Z nevrol psikhiatr im S S Korsakova 2022;122:86. [DOI: 10.17116/jnevro202212211186] [Reference Citation Analysis]
16 Jellinger KA. The pathobiological basis of depression in Parkinson disease: challenges and outlooks. J Neural Transm (Vienna) 2022;129:1397-418. [PMID: 36322206 DOI: 10.1007/s00702-022-02559-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]